Point72 Asset Management, L.P. 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:55 pm Sale |
2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Point72 Asset Management, L.P. | 2,300,643 2.900% |
-1,116,257 (-32.67%) |
Filing |
| 2024-02-14 4:14 pm Sale |
2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Point72 Asset Management, L.P. | 3,416,900 5.100% |
-311,052 (-8.34%) |
Filing |
| 2023-09-18 4:24 pm Purchase |
2023-09-15 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Point72 Asset Management, L.P. | 3,727,952 5.600% |
3,727,952 (New Position) |
Filing |